Merck
  • Home
  • Search Results
  • A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development.

A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development.

Human reproduction (Oxford, England) (2014-12-21)
Nicolas Chevalier, Françoise Brucker-Davis, Najiba Lahlou, Patrick Coquillard, Michel Pugeat, Patricia Pacini, Patricia Panaïa-Ferrari, Kathy Wagner-Mahler, Patrick Fénichel
ABSTRACT

Does a relationship exist between insulin-like peptide 3 (INSL3) and selected environmental endocrine disruptors (EEDs) in human cord blood (cb)? In the whole population (cryptorchid and control boys) cbINSL3 correlated negatively with cb free bisphenol A (BPA) providing indirect evidence for an impact of EEDs on fetal Leydig cell INSL3 production. INSL3 is a major regulator of testicular descent. This hormone has been shown to be decreased in cord blood from boys with idiopathic cryptorchidism, the most frequent male malformation. Fetal exposure to several EEDs has been suspected to be involved in the occurrence of idiopathic cryptorchidism. Correlations between cb INSL3 or testosterone and cb free bioactive BPA and maternal milk polychlorinated biphenyls (PCB153), dichlorodiphenyldichloroethylene (DDE), and monobutyl phthalate (mBP) were assessed in newborn boys in a prospective case-control study. All boys (n = 6246) born after 34 weeks of gestation were systematically screened at birth for cryptorchidism over a 3-year period (2002-2005), and a diagnosis of cryptorchidism confirmed by a senior paediatrician. We studied 52 cryptorchid (26 transient, 26 persistent) and 128 control boys born at two hospitals in southern France. INSL3 was assayed in CB by a modified validated enzyme-linked immunosorbent assay. Testosterone was measured in CB after diethyl-ether extraction by means of ultra-pressure liquid chromatography-tandem mass spectrometry. Free cbBPA was measured after an extraction step with a radioimmunoassay validated after comparison of values obtained by high-pressure liquid chromatography-mass spectrometry. The xenobiotic analysis in mothers' milk was performed after fat extraction by gas chromatography-mass spectrometry. EED concentrations were not increased in the cryptorchid versus control group although a trend for increased mBP (P = 0.09) was observed. In the whole study population, cb levels of BPA correlated negatively with INSL3 (P = 0.01; R² = 0.05) but not with testosterone. No other EED correlated with INSL3 or with testosterone. The levels of BPA and INSL3 in cb may not reflect chronic fetal exposure to EEDs. The deleterious impact of EEDs on fetal testicular descent during specific windows of development has yet to be demonstrated. The negative correlation between cb free BPA and INSL3 provides indirect evidence for an impact of EEDs on human fetal Leydig cell INSL3 production and points to cbINSL3 as a possible target of EED action during fetal testis development.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Sigma-Aldrich
二乙醚, contains 1 ppm BHT as inhibitor, anhydrous, ≥99.7%
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.7%
Sigma-Aldrich
二乙醚, anhydrous, ACS reagent, ≥99.0%, contains BHT as inhibitor
Sigma-Aldrich
乙酸乙酯, anhydrous, 99.8%
Sigma-Aldrich
二乙醚, suitable for HPLC, ≥99.9%, inhibitor-free
Sigma-Aldrich
乙酸乙酯, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
二乙醚, ACS reagent, anhydrous, ≥99.0%, contains BHT as inhibitor
Sigma-Aldrich
二乙醚, contains BHT as inhibitor, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Supelco
乙酸乙酯, analytical standard
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.8%
Supelco
乙酸乙酯, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
乙酸乙酯, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, natural, ≥99%, FCC, FG
Supelco
二乙醚, analytical standard
Sigma-Aldrich
乙酸乙酯, ≥99%, FCC, FG
Sigma-Aldrich
二乙醚, ACS reagent, ≥98.0%, contains ≤2% ethanol and ≤10ppm BHT as inhibitor
Supelco
4,4'-DDE, PESTANAL®, analytical standard
Sigma-Aldrich
二乙醚, reagent grade, ≥98%, contains ≤2% ethanol and ≤10ppm BHT as inhibitor
Sigma-Aldrich
乙酸乙酯, ReagentPlus®, ≥99.8%
Sigma-Aldrich
二乙醚, puriss., contains ~5 mg/L 2,6-di-tert.-butyl-4-methylphenol as stabilizer, meets analytical specification of Ph. Eur., BP, ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Supelco
邻苯二甲酸单丁酯, analytical standard
Sigma-Aldrich
邻苯二甲酸单丁酯, 97.0-103.0% (T)
Sigma-Aldrich
乙酸乙酯, biotech. grade, ≥99.8%
Supelco
乙酸乙酯, HPLC grade, 99.8%
Sigma-Aldrich
1,1-二氯-2,2-双(4-氯苯基)乙烯, 99%
Sigma-Aldrich
乙酸乙酯